Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

β3Gn-T1 Activators

β3Gn-T1, also known as β-1,3-N-acetylglucosaminyltransferase 1, is an enzyme involved in the biosynthesis of complex N-glycans, which are carbohydrate structures attached to proteins and play essential roles in various cellular processes such as cell adhesion, signaling, and immune response. As a member of the glycosyltransferase family, β3Gn-T1 catalyzes the transfer of N-acetylglucosamine (GlcNAc) residues from UDP-GlcNAc to specific glycoprotein substrates, thereby initiating the formation of complex N-glycan chains. The function of β3Gn-T1 is crucial for the proper glycosylation of proteins, as it determines the structure and composition of N-glycans, which in turn influences protein folding, stability, trafficking, and function. Additionally, β3Gn-T1-mediated glycosylation events have been implicated in cell-cell interactions, immune recognition, and the regulation of cellular signaling pathways.

The activation of β3Gn-T1 involves complex regulatory mechanisms that govern its expression, localization, and enzymatic activity. Transcriptional regulation plays a key role in activating β3Gn-T1, with various signaling pathways and transcription factors influencing its gene expression in response to cellular stimuli or developmental cues. Additionally, post-translational modifications such as phosphorylation or glycosylation may regulate the activity or stability of β3Gn-T1, thereby modulating its catalytic efficiency and substrate specificity. Furthermore, the availability of substrates and co-factors, such as UDP-GlcNAc and divalent metal ions, may influence the enzymatic activity of β3Gn-T1 and contribute to its activation. Elucidating the precise mechanisms underlying β3Gn-T1 activation will provide valuable insights into its physiological roles in glycosylation processes and its implications in health and disease.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin promotes the production of cAMP, which activates PKA. PKA, in turn, increases the phosphorylation of proteins involved in the same signaling pathways as β3Gn-T1, enhancing its activity.

Adenosine 3′,5′-cyclic monophosphate

60-92-4sc-217584
sc-217584A
sc-217584B
sc-217584C
sc-217584D
sc-217584E
100 mg
250 mg
5 g
10 g
25 g
50 g
$116.00
$179.00
$265.00
$369.00
$629.00
$1150.00
(1)

cAMP directly activates Protein Kinase A (PKA). PKA phosphorylation leads to the activation of proteins functionally linked with β3Gn-T1, thus enhancing its activity.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX inhibits phosphodiesterases, which degrade cAMP. By elevating cAMP levels, IBMX can indirectly enhance β3Gn-T1 by activating PKA, which phosphorylates proteins in the β3Gn-T1 functional pathway.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

8-Bromo-cAMP, a cell-permeable cAMP analog, activates PKA which then phosphorylates proteins within the same functional pathway as β3Gn-T1, enhancing its activity.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

H-89 inhibits PKA, thereby modulating the phosphorylation status of proteins within the β3Gn-T1 functional pathway, indirectly enhancing β3Gn-T1 activity.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a potent inhibitor of protein kinases like PKA. By modulating the phosphorylation status of proteins in the β3Gn-T1 pathway, it indirectly augments β3Gn-T1 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 inhibits PI3K, which can decrease Akt pathway activity. This decrease indirectly enhances β3Gn-T1 activity by reducing competitive signaling.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin inhibits PI3K, leading to a decrease in Akt activity. This can indirectly enhance β3Gn-T1 activity by reducing competition in signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which can indirectly enhance β3Gn-T1 activity by reducing Akt activity and subsequent competitive signaling.

BEZ235

915019-65-7sc-364429
50 mg
$211.00
8
(1)

BEZ235 inhibits both PI3K and mTOR, reducing Akt activity and enhancing β3Gn-T1 activity indirectly through decreased competition in signaling.